ByNobleID
    Exclusive patent license and nonexclusive know-how license to develop, make, use, have made, sell and sublicense products containing MLN 4760 or other biotherapeutic compound, including ACE2 inhibitors, to prevent, diagnose and treat human diseases, excluding oncology diseases, Type 1 and Type 2 diabetes, and obesity | NobleID